Article

Sightpath expands social media efforts

Sightpath, a provider of mobile and fixed ophthalmic surgical products, ramped up social media efforts with Facebook, Twitter, Vimeo, LinkedIn, and a blog.

Bloomington, MN-Sightpath, a provider of mobile and fixed ophthalmic surgical products, has created a company blog, a Facebook page, a Twitter account, and a Vimeo channel, as well as a fortified LinkedIn profile.

The expanded social media efforts are designed to provide additional avenues for communication, networking with peers, and keeping abreast of industry advancements.

“We believe that our social media presence will provide the company with the means to develop deeper relationships and interaction with our customers, employees, and partners, and will give us the ability to respond to feedback virtually in real time,” said Jim Tiffany, president and chief executive officer for Sightpath Medical.

All of Sightpath’s social media efforts are supported by the company’s Web site, www.SightpathMedical.com, which was re-launched earlier this year. From that site, visitors can learn about the company’s customizable products, browse video content depicting mobilization in action, hear from customers, and log in to create customized marketing materials.

“The way in which people search for information and connect to those they do business with is evolving. Sightpath recognizes this trend,” said Nicole Monacell, director of marketing for Sightpath Medical. “We’re looking forward to communicating and interacting with our customers in a new way.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.